(1) Shaheen NJ, Sharma P, et al. Radiofrequency Ablation in Barrett’s Esophagus with Dysplasia. New England Journal of Medicine 2009 May; 360(22):2277-2288.
(2) Phoa KY, van Vilsteren FG, Pouw RE, Bergman J et al. Radiofrequency Ablation vs Endoscopic Surveillance for Patients with Barrett Esophagus and Low-Grade Dysplasia A Randomized Clinical Trial. JAMA. 2014; 311(12):1-10.
(3) Spechler et al. Barrett’s Esophagus. N Engl J Med 2014; 371:836-45.
(4) Vaezi M, Zehrai A, Yuksel E, Testing for refractory gastroesophageal reflux disease, ASGE Leading Edge, 2012 Vol 2, No 2, 1-13, American Society Gastroenterology Esdoscopy, Page 1.
(5) Gilbert EW et al. Barrett’s esophagus: a review of the literature. J Gastrointest Surg 2011;15:708-1.
(6) Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-55.
(7) Dymedex Market Development Consulting, Strategic Market Assessment, Barrx, October 30, 2014. References 1, 3-5, 7-13, 15, 16, 20-23, 25, 27-29, 40-44, 46, 48-50, 54-59, 62-66, 68-75, 78, 79, 81, 82, 87-89, and 97 from the full citation list, access at http://www.medtronic.com/giclaims.
(8) Revista de Gastroenterología de México (English Edition), Volume 81, Issue 4, October–December 2016, Pages 208-222.